Market Scenario 

US smart home healthcare market was valued at US$ 8.48 billion in 2024 and is projected to hit the market valuation of US$ 65.46 billion by 2033 at a CAGR of 25.30% during the forecast period 2025–2033.

The United States smart home healthcare market is on a trajectory of explosive growth, driven by a confluence of urgent healthcare needs and powerful demographic shifts. The sheer scale of the aging population, with the number of Americans aged 65 and older projected to hit 77 million by 2034, creates an undeniable and sustained demand for solutions that support aging in place. This is not merely a trend but a fundamental reshaping of healthcare delivery, moving from institutional settings to the home. The staggering frequency of fall-related incidents, with an older adult falling every second of every day, underscores the critical need for preventative technologies. As a result, the deployment of fall detection devices has already reached 2.7 million units, signaling a market that is actively responding to one of the most pressing safety challenges for seniors.

The future potential lies in the seamless integration of disparate technologies into a cohesive home health ecosystem. The rapid consumer adoption of wearable technology, with global shipments expected to reach 440 million units by 2024, provides a massive data pipeline that can fuel proactive and personalized care models. As these devices and apps become more sophisticated, incorporating AI and connecting with smart home infrastructure, they will transition from passive trackers to active health management partners. This evolution promises to enhance independence, improve health outcomes, and alleviate the immense pressure on the traditional healthcare system, positioning the smart home as the central hub for the future of American wellness. 

Key Market Findings in US Smart Home Healthcare Market 

• Pervasive Fall Risk: Falls represent a national health crisis, with approximately 36 million reported among older adults annually, leading to over 32,000 deaths and 3 million emergency department visits each year.
• Surging RPM Adoption: The use of Remote Patient Monitoring (RPM) is expanding rapidly, with projections showing that 71 million Americans will utilize these services by 2025, up from just over 23 million in 2020.
• Economic Pressures on Seniors: Financial constraints are a significant factor driving the need for affordable home care, as 67% of seniors report that cost-of-living increases are making it more difficult to age in place.
• Dominance of Nutrition Apps: Digital diet and nutrition platforms have achieved massive scale, with the user base reaching 1.4 billion in 2022 and over half of surveyed individuals having used such an app to manage their dietary habits.
• Critical Role in Medication Adherence: Smart memory aids are addressing a vital healthcare gap, as medication non-adherence is responsible for an estimated 125,000 preventable deaths and 25% of all hospitalizations in the U.S. annually.
• Enhanced Sense of Independence: A primary benefit driving adoption is the feeling of empowerment, with 55% of users reporting they feel more independent and 49% feeling safer with the aid of smart home health technologies.

To Get more Insights,  Request A Free Sample 

Trend Analysis: 4 Forces Shaping the U.S. Smart Home Healthcare Market 

1. The Expansion of "Hospital-at-Home" and Acute Care Models

Driven by both clinical necessity and evolving reimbursement policies, the "Hospital-at-Home" model is a fast-emerging trend that heavily relies on smart home health technology. This model allows patients who would otherwise be hospitalized to receive acute-level care in their own residences. In 2025, numerous leading health systems across the U.S. have established formal Hospital-at-Home programs, treating conditions like pneumonia, heart failure, and COPD. These programs deploy kits that include smart thermometers, pulse oximeters, blood pressure cuffs, and often a connected tablet for daily telehealth visits. 

The use of Remote Patient Monitoring (RPM) is central to this, enabling continuous oversight. The success of these programs is evident, with several studies showing they can lead to better patient outcomes and higher satisfaction. This trend is solidifying the home as a viable and effective setting for managing serious health conditions that previously required inpatient stays.

2. The Creation of Seamless, Interoperable Health Ecosystems

The market is moving decisively beyond standalone gadgets to fully integrated wellness ecosystems. The key trend is interoperability, where devices communicate to create a holistic health profile. For example, a smart bed detecting poor sleep can trigger adjustments in smart lighting while flagging the data in a health app for correlation with diet or activity. This creation of a seamless data flow is a defining characteristic of the modern United States smart home healthcare market, making health management more intuitive and context-aware.

3. Heightened Focus on Data Security and Building Consumer Trust

With nearly 50 million people in the U.S. using remote patient monitoring devices, data security has become a paramount concern. A major trend within the United States smart home healthcare market is the heightened focus on building consumer trust through robust security measures. Manufacturers are prioritizing end-to-end encryption and transparent, HIPAA-compliant data policies. In 2025, a company's reputation for protecting sensitive health information is no longer just a feature but a critical factor for market success and user adoption.

4. The "Caregiver Tech" Boom: Empowering Informal Caregivers

A significant growth area is "Caregiver Tech"—solutions designed specifically for the millions of informal caregivers. This trend in the United States smart home healthcare market focuses on platforms and apps that provide family members with real-time insight into a loved one's well-being, such as medication adherence or daily activity levels. These tools provide essential peace of mind for caregivers while enhancing the user's quality of life; a key finding shows these technologies make 55% of primary users feel more independent, directly benefiting the entire care network.

Segmental Analysis 

By Product Type 

By capturing more than 77% market share, the dominance of testing, screening, and monitoring products in the United States smart home healthcare market represents a paradigm shift from reactive to proactive healthcare in the American home. This segment is thriving because it directly addresses the critical need for continuous, data-driven oversight of chronic conditions. The convenience of performing tests at home is a powerful motivator for patient engagement; for instance, the availability of at-home HIV self-testing kits has been shown to double the uptake of testing. This enhanced adherence is crucial, especially considering that studies show less than 35% of patients traditionally adhere to vital post-surgery rehabilitation programs. The market is further propelled by a favorable regulatory environment, with the FDA actively greenlighting a wave of sophisticated, AI-powered devices that promise greater accuracy and ease of use, building patient and provider trust.

This regulatory support is creating a vibrant ecosystem of innovation in the US smart home healthcare market. The FDA has cleared over 1,000 clinical artificial intelligence algorithms for medical use as of early 2025 and authorized 221 AI or machine learning-enabled devices in 2023 alone—a monumental increase from just six in 2015. This includes groundbreaking technologies like Mindset Medical's app, cleared in June 2025 to measure respiratory rate via a smartphone camera, and Subtle Medical's AI software, cleared in July 2024 to enhance MRI imaging. The demand is palpable, with nearly half of U.S. adults aged 50 to 80 (48.1%) having already purchased an at-home medical test. As technology becomes more integrated, with a projected 21% of the U.S. population using VR headsets by 2025 for applications including therapy, this segment’s foundational role is set to expand even further.

• Regulatory Momentum: The FDA is accelerating the approval of smart health devices, with an average of about 20 new AI algorithm clearances per month.
• Specialized Device Approval: Recent clearances include the UbiqVue 2A wearable biosensor for monitoring 12 vital signs and the SmartMammo Dx AI algorithm for GE HealthCare mammography systems in late 2024.
• Significant Market Penetration: 48.1% of Americans aged 50-80 have purchased at-home medical tests, signaling strong consumer adoption.
• Proven Efficacy: The introduction of at-home HIV self-testing kits effectively doubled the rate of testing among target populations.
• Explosive Growth in AI: The number of AI/ML-enabled medical devices authorized by the FDA skyrocketed from just six in 2015 to 221 in 2023.

By Services 

Skilled nursing services are leading the united states smart home healthcare market by generating more than 28.80% revenue by masterfully blending expert clinical care with cutting-edge technology. The growing complexity of patient needs, particularly among an aging population with multiple comorbidities, necessitates the on-site expertise that only skilled nurses can provide. These professionals are no longer just visiting homes; they are managing sophisticated care ecosystems. Major agencies like LHC Group and Amedisys are at the forefront, equipping their staff with telehealth platforms for virtual consultations and remote patient monitoring (RPM) tools to track vitals between visits. This tech-forward approach allows for a level of continuous care and rapid intervention that was previously impossible, ensuring patient safety and improving outcomes while creating operational efficiencies.

The impact of this integration is evident in the data across the United States smart home healthcare market. A massive study involving 15,434 skilled nursing facilities (SNFs) and 4.4 million residents highlighted how telehealth psychiatry visits increased by 20.2% in facilities with high adoption. While overall SNF telemedicine use has moderated from a peak of 91% in 2020 to 61% in 2022, its strategic application remains potent in the US; for instance, simple adherence reminder calls to Medicaid patients boosted the transmission of blood pressure readings from 74.9% to an impressive 91.3%. This trend also reflects evolving patient preferences, with one study showing that for 60.20% of primary care patients, the scope of services was the most important attribute for home-based care. The market is also adapting to policy shifts, with SNF episodes without a preceding three-day hospitalization rising from 6% to 32% during the public health emergency, underscoring the growing trust in home-based skilled care.

• Telehealth Integration: In a study of 15,434 SNFs, telehealth accounted for 15% of routine visits and 37% of outpatient visits at its peak, demonstrating significant integration.
• Patient Preference for Comprehensive Care: A discrete choice experiment revealed that the scope of services was the single most important factor for 60.20% of primary care patients considering home-based options.
• Enhanced Patient Adherence: Targeted interventions, such as reminder calls, have proven highly effective, increasing the transmission of vital health data by patients from 74.9% to 91.3% in one cohort.
• Evolving Care Models: The share of SNF episodes for long-term care residents rose from 12% to 25% during the pandemic, while episodes without prior hospitalization soared from 6% to 32%, indicating a major shift toward home-centric skilled care.
• Informed Patient Choice: A strong preference for collaboration exists, with 59.8% of patients and 55.3% of caregivers wanting a joint decision-making process for their post-acute care plans.

By Indication 

The intense focus on cardiovascular disorders and hypertension within the United States smart home healthcare market is a direct response to the immense scale of the problem and the remarkable efficacy of technological solutions. As a result, it is controlling more than 24.50% market share. Wherein, heart disease remains a leading cause of death in the U.S., making effective management a top public health priority. Smart devices, including connected blood pressure cuffs and ECG monitors, empower patients and clinicians with a continuous stream of actionable data. This constant vigilance is the key to a successful management strategy, enabling early detection of adverse events, precise medication adjustments, and personalized lifestyle coaching. The financial and clinical returns are staggering, with studies confirming that remote monitoring significantly reduces hospital readmissions and mortality.

The data supporting this dominance are compelling in the smart home healthcare market. A cost-utility analysis published in a leading medical journal found that remote patient monitoring was associated with an astonishing 87% reduction in hospitalizations and a 77% reduction in deaths for certain patient groups, translating to per-patient cost savings of $11,472. Real-world evidence from providers like Cardiac Solutions reinforces this, showing a 50% reduction in 30-day readmissions in 2024 for patients in their RPM program. Engagement is also strong, with a 2025 study showing that out of 3,403 consented Medicare beneficiaries with stage 2 hypertension, 1,594 actively participated in an RPM program for a full year. Even modest improvements, such as an average 2.2 mm Hg reduction in systolic blood pressure for adherent Medicaid patients, have a massive cumulative impact on public health, proving this segment’s vital charge.

• Dramatic Reductions in Adverse Events: The American Heart Association found that telemonitoring for hypertension could slash heart attack and stroke rates by as much as 50%.
• Proven Cost-Effectiveness: A landmark analysis in the United States smart home healthcare market revealed RPM could generate per-patient cost reductions of $11,472, driven by an 87% decrease in hospitalizations and a 77% decrease in deaths.
• Real-World Readmission Prevention: A 2024 study of nearly 27,000 patients by a cardiac care provider demonstrated a 50% cut in 30-day hospital readmissions through RPM.
• High Patient Engagement and Success: Navigator-led hypertension programs have achieved blood pressure control in 81% of patients, with 91% of engaged participants reaching their goal in just seven weeks.
• Massive Public Health Potential: The Apple Heart Study successfully enrolled over 400,000 participants, showcasing the immense potential of consumer wearables to detect conditions like atrial fibrillation on a population scale.

By Application 

With over 68.90% market share, health status monitoring stands as the most widely adopted and efficient application in smart home healthcare market, fundamentally because it delivers on the ultimate goals of modern medicine: better patient outcomes, enhanced comfort, and lower costs. This segment’s success is anchored in its ability to support the entire care continuum, from post-acute recovery to long-term chronic disease management. The rapid expansion of "hospital-at-home" programs is the ultimate validation of this model. These programs provide acute, hospital-level care within a patient's residence, a concept overwhelmingly favored by patients, with 56% believing they recover faster at home. This preference is backed by data showing that remote monitoring can reduce hospital readmissions by up to 30%, according to the National Institutes of Health.

The infrastructure to support this shift is growing rapidly in the United States smart home healthcare market. As of March 2025, an impressive 391 healthcare facilities across 39 U.S. states have received approval to offer hospital-at-home services. Prominent institutions like New York's Mount Sinai Health System treated approximately 1,000 patients this way in 2024 and plan to double that number in 2025. The financial incentives are just as compelling, with a study on heart failure patients showing an annual cost reduction of around $8,000 per patient through remote monitoring. A broad Centers for Medicare & Medicaid Services analysis further confirmed these benefits, finding that remote care management programs led to a nearly 5% reduction in hospitalizations and a 2.3% decrease in emergency department visits, solidifying health status monitoring as the gold standard for efficient and patient-centric care.

• Rapid National Expansion: By March 2025, 391 healthcare facilities across 39 states were approved for hospital-at-home programs, indicating widespread institutional adoption.
• Strong Patient Preference and Confidence: A 2024 survey found 56% of people in the smart home healthcare market believe recovery is faster at home, and 82% feel comfortable managing a patient’s medications there.
• Growing Public Acceptance: Nearly half of all U.S. adults (47%) now view hospital-at-home care as an acceptable and viable alternative to a traditional inpatient stay.
• Demonstrated System-Wide Cost Savings: A CMS analysis of remote care management programs confirmed a nearly 5% reduction in hospitalizations and a 2.3% decrease in emergency department visits.
• Significant Per-Patient Financial Impact: A targeted study of a remote monitoring program for heart failure patients demonstrated a substantial annual cost reduction of approximately $8,000 per patient.

 To Understand More About this Research:  Request A Free Sample 

 Top 10 Developments in Showing Growth Plans of Market Players in United States Smart Home Healthcare Market

• AI-Driven Platforms Attract Massive Funding: Startups with AI-powered remote patient monitoring (RPM) and chronic care platforms dominated recent fundraising. Demonstrating clear investor confidence, RPM startups raised nearly $1 billion between 2024 and mid-2025, with AI-driven firms like Biofourmis and Forward Health securing the largest rounds.
• Strategic Merger of Home Care Giants: In a major consolidation, in-home care providers DispatchHealth and Medically Home merged in June 2025. The merger creates one of the nation's largest high-acuity hospital-at-home companies, combining virtual care command centers with an extensive in-person service network to deliver complex care directly to patient homes.
• Venture Capital Investment Rebounds with Focus on AI: After a decline, venture capital funding in U.S. digital health rebounded in 2024, reaching $17.2 billion. AI-enabled startups were the main beneficiaries, capturing 58% of this funding. By the first half of 2025, AI companies secured an even larger share at 62% of all digital health venture funding.
• Telehealth Leader Teladoc on an Acquisition Spree: Signaling a renewed growth strategy, Teladoc Health made two key acquisitions in early 2025. The company acquired at-home diagnostics firm Catapult Health and virtual mental health provider UpLift to bolster its chronic care management and therapy services.
• Private Equity Drives "Roll-Up" Strategy: Private equity firms in the United States smart home healthcare market became more active in 2025, employing a "roll-up" strategy. This involves acquiring and combining AI-native startups with legacy healthcare providers to leverage established distribution and trust with cutting-edge AI efficiency.
• RPM Company CoachCare Secures Over $110 Million: Remote patient monitoring firm CoachCare raised over $110 million in debt and equity in 2024 to fuel its growth. The funding enabled M&A activity, including its recent acquisitions of Dedica Health and Revolution Health Solutions.
• Best Buy Health Restructures, Divests from Current Health: In a major strategic shift, Best Buy Health sold the at-home care tech company Current Health back to its founder in June 2025. The move followed significant financial losses, including a $475 million impairment charge, signaling Best Buy's pivot from the "hospital-at-home" market to focus on its consumer senior health products.
• Fall Detection Innovator Nobi Lands €35 Million: Nobi, a developer of AI-powered smart lamps for fall detection, closed a €35 million Series B round in January 2025. Co-led by U.S.-based Nexus NeuroTech Ventures, the investment will expand its technology, which is already being deployed in the U.S. through a deal with Frontier Senior Living across 56 care centers.
• Vertical Integration a Key Theme for Retail and Tech Giants: Major corporations are pursuing vertical integration to build comprehensive healthcare ecosystems. Amazon's $3.9 billion acquisition of One Medical exemplifies this trend, blending technology with primary care delivery. Companies are acquiring different parts of the supply chain to create seamless, end-to-end patient experiences.
• Telehealth M&A Accelerates to Build Comprehensive Platforms: The telehealth sector is consolidating as companies build broader service offerings. In April 2025, LifeMD acquired assets from Optimal Human Health MD to launch a comprehensive virtual women's health platform. This "tapestry weaving" acquisition strategy, where companies buy new capabilities, accounted for 63% of M&A deals in early 2025.

Top Companies in the US Smart Home Healthcare Market

• Apple Inc.
• General Electric Company
• Abbott Laboratories
• AT&T Inc.
• F. Hoffmann-La Roche Ltd
• Fitbit Inc.
• Siemens AG
• Samsung Electronics Co. Ltd.
• Qualcomm Technologies, Inc.
• Medtronic
• Koninklijke Philips N.V.
• BSH Home Appliances Group
• Resideo Technologies, Inc.
• Schneider Electric SE
• Other Prominent Players

Market Segmentation Overview:

By Technology

• Wired
• Wireless

By Products

• Testing, Screening and Monitoring Products
• Therapeutic Products
• Mobile Care Products

By Service

• Skilled Nursing Services
• Rehabilitation Therapy Services
• Hospice and Palliative Care Services
• Unskilled Care Services
• Respiratory Therapy Services
• Infusion Therapy Services
• Pregnancy Care Services

By Application

• Fall Prevention and Detection
• Health Status Monitoring
• Nutrition or Diet Monitoring
• Memory Aids

By Indication

• Diabetes
• Respiratory Diseases
• Pregnancy
• Mobility Disorders
• Hearing Disorders
• Cancer
• Wound Care